These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30578663)

  • 1. Naringenin Supplementation to a Chow Diet Enhances Energy Expenditure and Fatty Acid Oxidation, and Reduces Adiposity in Lean, Pair-Fed Ldlr
    Burke AC; Telford DE; Edwards JY; Sutherland BG; Sawyez CG; Huff MW
    Mol Nutr Food Res; 2019 Mar; 63(6):e1800833. PubMed ID: 30578663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
    Mulvihill EE; Assini JM; Sutherland BG; DiMattia AS; Khami M; Koppes JB; Sawyez CG; Whitman SC; Huff MW
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):742-8. PubMed ID: 20110573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naringenin enhances the regression of atherosclerosis induced by a chow diet in Ldlr
    Burke AC; Sutherland BG; Telford DE; Morrow MR; Sawyez CG; Edwards JY; Huff MW
    Atherosclerosis; 2019 Jul; 286():60-70. PubMed ID: 31102954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citrus flavonoid, naringenin, increases locomotor activity and reduces diacylglycerol accumulation in skeletal muscle of obese ovariectomized mice.
    Ke JY; Cole RM; Hamad EM; Hsiao YH; Cotten BM; Powell KA; Belury MA
    Mol Nutr Food Res; 2016 Feb; 60(2):313-24. PubMed ID: 26573879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leucine supplementation protects from insulin resistance by regulating adiposity levels.
    Binder E; Bermúdez-Silva FJ; André C; Elie M; Romero-Zerbo SY; Leste-Lasserre T; Belluomo I; Duchampt A; Clark S; Aubert A; Mezzullo M; Fanelli F; Pagotto U; Layé S; Mithieux G; Cota D
    PLoS One; 2013; 8(9):e74705. PubMed ID: 24086364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice.
    Srivastava RA; Jahagirdar R; Azhar S; Sharma S; Bisgaier CL
    Mol Cell Biochem; 2006 Apr; 285(1-2):35-50. PubMed ID: 16477380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance.
    Mulvihill EE; Allister EM; Sutherland BG; Telford DE; Sawyez CG; Edwards JY; Markle JM; Hegele RA; Huff MW
    Diabetes; 2009 Oct; 58(10):2198-210. PubMed ID: 19592617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intervention with citrus flavonoids reverses obesity and improves metabolic syndrome and atherosclerosis in obese
    Burke AC; Sutherland BG; Telford DE; Morrow MR; Sawyez CG; Edwards JY; Drangova M; Huff MW
    J Lipid Res; 2018 Sep; 59(9):1714-1728. PubMed ID: 30008441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity and mRNA levels of enzymes involved in hepatic fatty acid oxidation in mice fed citrus flavonoids.
    Huong DT; Takahashi Y; Ide T
    Nutrition; 2006 May; 22(5):546-52. PubMed ID: 16483743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citrus flavonoid naringenin reduces mammary tumor cell viability, adipose mass, and adipose inflammation in obese ovariectomized mice.
    Ke JY; Banh T; Hsiao YH; Cole RM; Straka SR; Yee LD; Belury MA
    Mol Nutr Food Res; 2017 Sep; 61(9):. PubMed ID: 28370954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary naringenin increases hepatic peroxisome proliferators-activated receptor α protein expression and decreases plasma triglyceride and adiposity in rats.
    Cho KW; Kim YO; Andrade JE; Burgess JR; Kim YC
    Eur J Nutr; 2011 Mar; 50(2):81-8. PubMed ID: 20567977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with the TGF-b superfamily cytokine MIC-1/GDF15 reduces the adiposity and corrects the metabolic dysfunction of mice with diet-induced obesity.
    Tsai VW; Zhang HP; Manandhar R; Lee-Ng KKM; Lebhar H; Marquis CP; Husaini Y; Sainsbury A; Brown DA; Breit SN
    Int J Obes (Lond); 2018 Mar; 42(3):561-571. PubMed ID: 29026214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. d-Allulose supplementation normalized the body weight and fat-pad mass in diet-induced obese mice via the regulation of lipid metabolism under isocaloric fed condition.
    Han Y; Han HJ; Kim AH; Choi JY; Cho SJ; Park YB; Jung UJ; Choi MS
    Mol Nutr Food Res; 2016 Jul; 60(7):1695-706. PubMed ID: 26920079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
    Assini JM; Mulvihill EE; Burke AC; Sutherland BG; Telford DE; Chhoker SS; Sawyez CG; Drangova M; Adams AC; Kharitonenkov A; Pin CL; Huff MW
    Endocrinology; 2015 Jun; 156(6):2087-102. PubMed ID: 25774553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential adverse effects of botanical supplementation in high-fat-fed female mice.
    Fuller S; Yu Y; Mendoza T; Ribnicky DM; Cefalu WT; Floyd ZE
    Biol Sex Differ; 2018 Sep; 9(1):41. PubMed ID: 30208938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of fatty acid oxidation resists weight gain, ameliorates hepatic steatosis and reduces cardiometabolic risk factors.
    Vijayakumar RS; Lin Y; Shia KS; Yeh YN; Hsieh WP; Hsiao WC; Chang CP; Chao YS; Hung MS
    Int J Obes (Lond); 2012 Jul; 36(7):999-1006. PubMed ID: 21894162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Kv1.3 channel blocker as therapeutic for obesity and insulin resistance.
    Upadhyay SK; Eckel-Mahan KL; Mirbolooki MR; Tjong I; Griffey SM; Schmunk G; Koehne A; Halbout B; Iadonato S; Pedersen B; Borrelli E; Wang PH; Mukherjee J; Sassone-Corsi P; Chandy KG
    Proc Natl Acad Sci U S A; 2013 Jun; 110(24):E2239-48. PubMed ID: 23729813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice.
    Coenen KR; Hasty AH
    Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E492-9. PubMed ID: 17566116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary Eriodictyol Alleviates Adiposity, Hepatic Steatosis, Insulin Resistance, and Inflammation in Diet-Induced Obese Mice.
    Kwon EY; Choi MS
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30862092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
    Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
    Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.